Hepcidin Serum Levels and Resistance to Recombinant Human Erythropoietin Therapy in Haemodialysis Patients

Publisher： Karger

E-ISSN： 1421-9662|122|4|226-229

ISSN： 0001-5792

Source： Acta Haematologica, Vol.122, Iss.4, 2009-10, pp. : 226-229

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

DMT1 (NRAMP2/DCT1) Genetic Variability and Resistance to Recombinant Human Erythropoietin Therapy in Chronic Kidney Disease Patients under Haemodialysis

By  

Acta Haematologica, Vol. 120, Iss. 1, 2008-08 ,pp. : 11-13

Karger

Access to resources Recommend Favorite

Recombinant Human Erythropoietin Is Associated with Increased Overall Survival in Patients with Multiple Myeloma

By  

Acta Haematologica, Vol. 117, Iss. 3, 2006-12 ,pp. : 162-167

Karger

Access to resources Recommend Favorite

Recombinant Human Erythropoietin for the Treatment of Anaemia in Patients with Chronic Idiopathic Myelofibrosis

By  

Acta Haematologica, Vol. 117, Iss. 3, 2006-12 ,pp. : 156-161

Karger

Access to resources Recommend Favorite

Evaluation of Tumor Necrosis Factor-α and Erythropoietin Serum Levels in B-Cell Chronic Lymphocytic Leukemia Patients with Anemia

By  

Acta Haematologica, Vol. 108, Iss. 2, 2002-08 ,pp. : 84-89

Karger

Access to resources Recommend Favorite

Serum 25(OH)-Cholecalciferol Concentration Is Associated with Hemoglobin Level and Erythropoietin Resistance in Patients on Maintenance Hemodialysis

By  

Nephron Clin Pract, Vol. 117, Iss. 4, 2010-11 ,pp. : 373-378

Karger

Access to resources Recommend Favorite